nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Timolol—migraine	0.318	0.652	CrCtD
Levobunolol—Propranolol—migraine	0.169	0.347	CrCtD
Levobunolol—Penbutolol—Timolol—migraine	0.0778	0.309	CrCrCtD
Levobunolol—Bupranolol—Timolol—migraine	0.0618	0.246	CrCrCtD
Levobunolol—ADRB2—Timolol—migraine	0.0501	0.266	CbGbCtD
Levobunolol—ADRB1—Timolol—migraine	0.0494	0.262	CbGbCtD
Levobunolol—Carteolol—Propranolol—migraine	0.0455	0.181	CrCrCtD
Levobunolol—ADRB2—Propranolol—migraine	0.0447	0.237	CbGbCtD
Levobunolol—ADRB1—Propranolol—migraine	0.044	0.234	CbGbCtD
Levobunolol—Penbutolol—Propranolol—migraine	0.0414	0.165	CrCrCtD
Levobunolol—Pindolol—Propranolol—migraine	0.0249	0.0991	CrCrCtD
Levobunolol—Corneal sensitivity decreased—Timolol—migraine	0.0038	0.0785	CcSEcCtD
Levobunolol—Hypoaesthesia eye—Timolol—migraine	0.00237	0.049	CcSEcCtD
Levobunolol—Eyelid ptosis—Timolol—migraine	0.00218	0.0451	CcSEcCtD
Levobunolol—Block heart—Amitriptyline—migraine	0.00102	0.0211	CcSEcCtD
Levobunolol—Myasthenia gravis—Timolol—migraine	0.00102	0.021	CcSEcCtD
Levobunolol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.00093	0.0401	CbGpPWpGaD
Levobunolol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.00093	0.0401	CbGpPWpGaD
Levobunolol—Block heart—Propranolol—migraine	0.00083	0.0172	CcSEcCtD
Levobunolol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.000675	0.0291	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.000661	0.0285	CbGpPWpGaD
Levobunolol—Rash generalised—Timolol—migraine	0.000644	0.0133	CcSEcCtD
Levobunolol—Diabetic—Topiramate—migraine	0.000642	0.0133	CcSEcCtD
Levobunolol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.000628	0.0271	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.000614	0.0265	CbGpPWpGaD
Levobunolol—Atrioventricular block—Amitriptyline—migraine	0.000597	0.0123	CcSEcCtD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.000568	0.0245	CbGpPWpGaD
Levobunolol—Cerebral ischaemia—Timolol—migraine	0.000566	0.0117	CcSEcCtD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.000555	0.0239	CbGpPWpGaD
Levobunolol—Block heart—Valproic Acid—migraine	0.000542	0.0112	CcSEcCtD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.000528	0.0228	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.000516	0.0223	CbGpPWpGaD
Levobunolol—Atrioventricular block—Propranolol—migraine	0.000486	0.01	CcSEcCtD
Levobunolol—Block heart—Timolol—migraine	0.000482	0.00996	CcSEcCtD
Levobunolol—Block heart—Gabapentin—migraine	0.000449	0.00927	CcSEcCtD
Levobunolol—Atrioventricular block—Verapamil—migraine	0.000447	0.00923	CcSEcCtD
Levobunolol—Respiratory failure—Verapamil—migraine	0.000441	0.00912	CcSEcCtD
Levobunolol—Cerebrovascular accident—Amitriptyline—migraine	0.000429	0.00885	CcSEcCtD
Levobunolol—Keratitis—Timolol—migraine	0.000422	0.00871	CcSEcCtD
Levobunolol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000409	0.0176	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.0004	0.0173	CbGpPWpGaD
Levobunolol—Ataxia—Amitriptyline—migraine	0.000395	0.00816	CcSEcCtD
Levobunolol—Penbutolol—HTR1B—migraine	0.000394	0.264	CrCbGaD
Levobunolol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000394	0.017	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000385	0.0166	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.00038	0.0164	CbGpPWpGaD
Levobunolol—Cardiac failure congestive—Propranolol—migraine	0.000377	0.00779	CcSEcCtD
Levobunolol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000372	0.016	CbGpPWpGaD
Levobunolol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.00037	0.016	CbGpPWpGaD
Levobunolol—Visual disturbance—Propranolol—migraine	0.000361	0.00746	CcSEcCtD
Levobunolol—ADRB1—Endothelin Pathways—CALCA—migraine	0.000356	0.0154	CbGpPWpGaD
Levobunolol—Hypoglycaemia—Propranolol—migraine	0.00035	0.00724	CcSEcCtD
Levobunolol—Lethargy—Propranolol—migraine	0.000349	0.00721	CcSEcCtD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000344	0.0148	CbGpPWpGaD
Levobunolol—Stinging—Timolol—migraine	0.000338	0.00698	CcSEcCtD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000336	0.0145	CbGpPWpGaD
Levobunolol—Erectile dysfunction—Amitriptyline—migraine	0.000334	0.00691	CcSEcCtD
Levobunolol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000333	0.0144	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000331	0.0143	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000326	0.0141	CbGpPWpGaD
Levobunolol—Cardiac arrest—Propranolol—migraine	0.000325	0.00672	CcSEcCtD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000324	0.014	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000322	0.0139	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000322	0.0139	CbGpPWpGaD
Levobunolol—Cerebrovascular accident—Verapamil—migraine	0.000321	0.00663	CcSEcCtD
Levobunolol—Lethargy—Verapamil—migraine	0.000321	0.00663	CcSEcCtD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.00032	0.0138	CbGpPWpGaD
Levobunolol—Atrioventricular block—Valproic Acid—migraine	0.000317	0.00654	CcSEcCtD
Levobunolol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000315	0.0136	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.000315	0.0136	CbGpPWpGaD
Levobunolol—Diplopia—Verapamil—migraine	0.000315	0.0065	CcSEcCtD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000313	0.0135	CbGpPWpGaD
Levobunolol—Penbutolol—HTR1A—migraine	0.000312	0.209	CrCbGaD
Levobunolol—Cardiac arrest—Verapamil—migraine	0.000299	0.00618	CcSEcCtD
Levobunolol—Bronchospasm—Propranolol—migraine	0.000291	0.00601	CcSEcCtD
Levobunolol—Pindolol—HTR1B—migraine	0.000284	0.19	CrCbGaD
Levobunolol—Atrioventricular block—Timolol—migraine	0.000282	0.00583	CcSEcCtD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.00028	0.0121	CbGpPWpGaD
Levobunolol—Respiratory failure—Timolol—migraine	0.000279	0.00575	CcSEcCtD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000274	0.0118	CbGpPWpGaD
Levobunolol—Erectile dysfunction—Propranolol—migraine	0.000272	0.00562	CcSEcCtD
Levobunolol—Bronchospasm—Verapamil—migraine	0.000267	0.00552	CcSEcCtD
Levobunolol—Depression—Propranolol—migraine	0.000263	0.00543	CcSEcCtD
Levobunolol—Atrioventricular block—Gabapentin—migraine	0.000263	0.00543	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Propranolol—migraine	0.000261	0.0054	CcSEcCtD
Levobunolol—Arrhythmia—Amitriptyline—migraine	0.00026	0.00536	CcSEcCtD
Levobunolol—Respiratory failure—Gabapentin—migraine	0.000259	0.00536	CcSEcCtD
Levobunolol—Alopecia—Amitriptyline—migraine	0.000257	0.0053	CcSEcCtD
Levobunolol—Erectile dysfunction—Verapamil—migraine	0.00025	0.00517	CcSEcCtD
Levobunolol—Bradycardia—Propranolol—migraine	0.000241	0.00498	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Verapamil—migraine	0.00024	0.00497	CcSEcCtD
Levobunolol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000233	0.0101	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.000228	0.00984	CbGpPWpGaD
Levobunolol—Visual impairment—Propranolol—migraine	0.000228	0.00471	CcSEcCtD
Levobunolol—Lethargy—Valproic Acid—migraine	0.000228	0.0047	CcSEcCtD
Levobunolol—Syncope—Amitriptyline—migraine	0.000227	0.00469	CcSEcCtD
Levobunolol—Pindolol—HTR1A—migraine	0.000225	0.151	CrCbGaD
Levobunolol—Erythema multiforme—Propranolol—migraine	0.000224	0.00462	CcSEcCtD
Levobunolol—Palpitations—Amitriptyline—migraine	0.000224	0.00462	CcSEcCtD
Levobunolol—Diplopia—Valproic Acid—migraine	0.000223	0.00461	CcSEcCtD
Levobunolol—Loss of consciousness—Amitriptyline—migraine	0.000222	0.00459	CcSEcCtD
Levobunolol—Bradycardia—Verapamil—migraine	0.000222	0.00458	CcSEcCtD
Levobunolol—Atrioventricular block—Topiramate—migraine	0.000221	0.00456	CcSEcCtD
Levobunolol—Cardiac failure congestive—Timolol—migraine	0.000219	0.00452	CcSEcCtD
Levobunolol—Nasal congestion—Timolol—migraine	0.000218	0.0045	CcSEcCtD
Levobunolol—Diabetes mellitus—Gabapentin—migraine	0.000213	0.00439	CcSEcCtD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000211	0.00909	CbGpPWpGaD
Levobunolol—Ataxia—Valproic Acid—migraine	0.00021	0.00433	CcSEcCtD
Levobunolol—Visual impairment—Verapamil—migraine	0.00021	0.00433	CcSEcCtD
Levobunolol—Visual disturbance—Timolol—migraine	0.00021	0.00433	CcSEcCtD
Levobunolol—Alopecia—Propranolol—migraine	0.000209	0.00432	CcSEcCtD
Levobunolol—Confusional state—Amitriptyline—migraine	0.000208	0.0043	CcSEcCtD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000206	0.0089	CbGpPWpGaD
Levobunolol—Erythema multiforme—Verapamil—migraine	0.000206	0.00425	CcSEcCtD
Levobunolol—Cardiac failure congestive—Gabapentin—migraine	0.000204	0.00421	CcSEcCtD
Levobunolol—Hypoglycaemia—Timolol—migraine	0.000203	0.0042	CcSEcCtD
Levobunolol—Shock—Amitriptyline—migraine	0.000203	0.0042	CcSEcCtD
Levobunolol—Cerebrovascular accident—Timolol—migraine	0.000203	0.00419	CcSEcCtD
Levobunolol—Diplopia—Timolol—migraine	0.000199	0.0041	CcSEcCtD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000196	0.00846	CbGpPWpGaD
Levobunolol—Hypotension—Amitriptyline—migraine	0.000193	0.00398	CcSEcCtD
Levobunolol—Alopecia—Verapamil—migraine	0.000192	0.00397	CcSEcCtD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.000192	0.00827	CbGpPWpGaD
Levobunolol—Hypoglycaemia—Gabapentin—migraine	0.000189	0.00391	CcSEcCtD
Levobunolol—Cardiac arrest—Timolol—migraine	0.000189	0.0039	CcSEcCtD
Levobunolol—Cerebrovascular accident—Gabapentin—migraine	0.000189	0.0039	CcSEcCtD
Levobunolol—Lethargy—Gabapentin—migraine	0.000189	0.0039	CcSEcCtD
Levobunolol—Paraesthesia—Amitriptyline—migraine	0.000185	0.00383	CcSEcCtD
Levobunolol—Diplopia—Gabapentin—migraine	0.000185	0.00382	CcSEcCtD
Levobunolol—Diabetes mellitus—Topiramate—migraine	0.000179	0.00369	CcSEcCtD
Levobunolol—Cardiac arrest—Gabapentin—migraine	0.000176	0.00363	CcSEcCtD
Levobunolol—Ataxia—Gabapentin—migraine	0.000174	0.00359	CcSEcCtD
Levobunolol—Depression—Valproic Acid—migraine	0.000171	0.00354	CcSEcCtD
Levobunolol—Nasal congestion—Topiramate—migraine	0.000171	0.00353	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Valproic Acid—migraine	0.00017	0.00352	CcSEcCtD
Levobunolol—Feeling abnormal—Amitriptyline—migraine	0.00017	0.00351	CcSEcCtD
Levobunolol—Syncope—Verapamil—migraine	0.00017	0.00351	CcSEcCtD
Levobunolol—Bronchospasm—Timolol—migraine	0.000169	0.00349	CcSEcCtD
Levobunolol—Palpitations—Verapamil—migraine	0.000167	0.00346	CcSEcCtD
Levobunolol—Conjunctivitis—Valproic Acid—migraine	0.000167	0.00345	CcSEcCtD
Levobunolol—Loss of consciousness—Verapamil—migraine	0.000167	0.00344	CcSEcCtD
Levobunolol—Visual disturbance—Topiramate—migraine	0.000164	0.00339	CcSEcCtD
Levobunolol—Urticaria—Amitriptyline—migraine	0.000164	0.00339	CcSEcCtD
Levobunolol—Chest pain—Verapamil—migraine	0.000161	0.00333	CcSEcCtD
Levobunolol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000161	0.00693	CbGpPWpGaD
Levobunolol—Hypoglycaemia—Topiramate—migraine	0.000159	0.00329	CcSEcCtD
Levobunolol—Lethargy—Topiramate—migraine	0.000159	0.00328	CcSEcCtD
Levobunolol—Erectile dysfunction—Timolol—migraine	0.000158	0.00327	CcSEcCtD
Levobunolol—Bronchospasm—Gabapentin—migraine	0.000157	0.00325	CcSEcCtD
Levobunolol—Bradycardia—Valproic Acid—migraine	0.000157	0.00325	CcSEcCtD
Levobunolol—Confusional state—Verapamil—migraine	0.000156	0.00322	CcSEcCtD
Levobunolol—Diplopia—Topiramate—migraine	0.000156	0.00321	CcSEcCtD
Levobunolol—Propranolol—HTR1B—migraine	0.000155	0.104	CrCbGaD
Levobunolol—Depression—Timolol—migraine	0.000153	0.00315	CcSEcCtD
Levobunolol—Shock—Verapamil—migraine	0.000152	0.00314	CcSEcCtD
Levobunolol—Paraesthesia—Propranolol—migraine	0.000151	0.00312	CcSEcCtD
Levobunolol—Dyspnoea—Propranolol—migraine	0.00015	0.0031	CcSEcCtD
Levobunolol—Conjunctivitis—Timolol—migraine	0.000149	0.00307	CcSEcCtD
Levobunolol—Visual impairment—Valproic Acid—migraine	0.000149	0.00307	CcSEcCtD
Levobunolol—Asthenia—Amitriptyline—migraine	0.000148	0.00306	CcSEcCtD
Levobunolol—Erectile dysfunction—Gabapentin—migraine	0.000147	0.00304	CcSEcCtD
Levobunolol—Ataxia—Topiramate—migraine	0.000146	0.00302	CcSEcCtD
Levobunolol—Pruritus—Amitriptyline—migraine	0.000146	0.00302	CcSEcCtD
Levobunolol—Erythema multiforme—Valproic Acid—migraine	0.000146	0.00301	CcSEcCtD
Levobunolol—ADRB2—GPCRs, Other—HTR7—migraine	0.000145	0.00624	CbGpPWpGaD
Levobunolol—Hypotension—Verapamil—migraine	0.000144	0.00298	CcSEcCtD
Levobunolol—Pain—Propranolol—migraine	0.000144	0.00297	CcSEcCtD
Levobunolol—Depression—Gabapentin—migraine	0.000142	0.00294	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Gabapentin—migraine	0.000141	0.00292	CcSEcCtD
Levobunolol—Diarrhoea—Amitriptyline—migraine	0.000141	0.00292	CcSEcCtD
Levobunolol—Bradycardia—Timolol—migraine	0.00014	0.00289	CcSEcCtD
Levobunolol—Paraesthesia—Verapamil—migraine	0.000139	0.00287	CcSEcCtD
Levobunolol—Conjunctivitis—Gabapentin—migraine	0.000139	0.00286	CcSEcCtD
Levobunolol—Arrhythmia—Valproic Acid—migraine	0.000138	0.00285	CcSEcCtD
Levobunolol—Dyspnoea—Verapamil—migraine	0.000138	0.00285	CcSEcCtD
Levobunolol—Dizziness—Amitriptyline—migraine	0.000137	0.00282	CcSEcCtD
Levobunolol—Alopecia—Valproic Acid—migraine	0.000136	0.00282	CcSEcCtD
Levobunolol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.000135	0.0058	CbGpPWpGaD
Levobunolol—Urticaria—Propranolol—migraine	0.000134	0.00276	CcSEcCtD
Levobunolol—Visual impairment—Timolol—migraine	0.000132	0.00273	CcSEcCtD
Levobunolol—Pain—Verapamil—migraine	0.000132	0.00273	CcSEcCtD
Levobunolol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000132	0.00567	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00013	0.00562	CbGpPWpGaD
Levobunolol—Bradycardia—Gabapentin—migraine	0.00013	0.00269	CcSEcCtD
Levobunolol—Headache—Amitriptyline—migraine	0.000129	0.00267	CcSEcCtD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000127	0.0055	CbGpPWpGaD
Levobunolol—Feeling abnormal—Verapamil—migraine	0.000127	0.00263	CcSEcCtD
Levobunolol—Hypersensitivity—Propranolol—migraine	0.000124	0.00256	CcSEcCtD
Levobunolol—Erectile dysfunction—Topiramate—migraine	0.000124	0.00256	CcSEcCtD
Levobunolol—ADRB1—G alpha (s) signalling events—CALCA—migraine	0.000124	0.00533	CbGpPWpGaD
Levobunolol—Visual impairment—Gabapentin—migraine	0.000123	0.00255	CcSEcCtD
Levobunolol—Urticaria—Verapamil—migraine	0.000123	0.00254	CcSEcCtD
Levobunolol—Arrhythmia—Timolol—migraine	0.000123	0.00254	CcSEcCtD
Levobunolol—Nausea—Amitriptyline—migraine	0.000123	0.00253	CcSEcCtD
Levobunolol—Propranolol—HTR1A—migraine	0.000123	0.0822	CrCbGaD
Levobunolol—Alopecia—Timolol—migraine	0.000121	0.00251	CcSEcCtD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000121	0.00522	CbGpPWpGaD
Levobunolol—Erythema multiforme—Gabapentin—migraine	0.000121	0.0025	CcSEcCtD
Levobunolol—ADRB2—G alpha (s) signalling events—CALCA—migraine	0.000121	0.00521	CbGpPWpGaD
Levobunolol—Asthenia—Propranolol—migraine	0.000121	0.00249	CcSEcCtD
Levobunolol—Depression—Topiramate—migraine	0.00012	0.00247	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Topiramate—migraine	0.000119	0.00246	CcSEcCtD
Levobunolol—Palpitations—Valproic Acid—migraine	0.000119	0.00245	CcSEcCtD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000119	0.00511	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CALCRL—migraine	0.000117	0.00505	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—RAMP1—migraine	0.000117	0.00505	CbGpPWpGaD
Levobunolol—Conjunctivitis—Topiramate—migraine	0.000117	0.00241	CcSEcCtD
Levobunolol—ADRB1—G alpha (s) signalling events—HTR7—migraine	0.000116	0.00498	CbGpPWpGaD
Levobunolol—Diarrhoea—Propranolol—migraine	0.000115	0.00238	CcSEcCtD
Levobunolol—ADRB2—GPCR ligand binding—RAMP1—migraine	0.000114	0.00494	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CALCRL—migraine	0.000114	0.00494	CbGpPWpGaD
Levobunolol—Chest pain—Valproic Acid—migraine	0.000114	0.00236	CcSEcCtD
Levobunolol—Hypersensitivity—Verapamil—migraine	0.000114	0.00235	CcSEcCtD
Levobunolol—Alopecia—Gabapentin—migraine	0.000113	0.00234	CcSEcCtD
Levobunolol—ADRB2—G alpha (s) signalling events—HTR7—migraine	0.000113	0.00487	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000112	0.00481	CbGpPWpGaD
Levobunolol—Dizziness—Propranolol—migraine	0.000111	0.0023	CcSEcCtD
Levobunolol—Asthenia—Verapamil—migraine	0.000111	0.00229	CcSEcCtD
Levobunolol—Confusional state—Valproic Acid—migraine	0.000111	0.00228	CcSEcCtD
Levobunolol—Bradycardia—Topiramate—migraine	0.00011	0.00226	CcSEcCtD
Levobunolol—Pruritus—Verapamil—migraine	0.000109	0.00226	CcSEcCtD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000109	0.00471	CbGpPWpGaD
Levobunolol—Syncope—Timolol—migraine	0.000107	0.00222	CcSEcCtD
Levobunolol—Diarrhoea—Verapamil—migraine	0.000106	0.00219	CcSEcCtD
Levobunolol—Palpitations—Timolol—migraine	0.000106	0.00218	CcSEcCtD
Levobunolol—Loss of consciousness—Timolol—migraine	0.000105	0.00217	CcSEcCtD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000104	0.00448	CbGpPWpGaD
Levobunolol—Visual impairment—Topiramate—migraine	0.000104	0.00214	CcSEcCtD
Levobunolol—Hypotension—Valproic Acid—migraine	0.000102	0.00212	CcSEcCtD
Levobunolol—Dizziness—Verapamil—migraine	0.000102	0.00211	CcSEcCtD
Levobunolol—Chest pain—Timolol—migraine	0.000102	0.0021	CcSEcCtD
Levobunolol—Erythema multiforme—Topiramate—migraine	0.000102	0.0021	CcSEcCtD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000102	0.00438	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—HTR2A—migraine	0.000101	0.00437	CbGpPWpGaD
Levobunolol—Syncope—Gabapentin—migraine	9.99e-05	0.00206	CcSEcCtD
Levobunolol—Nausea—Propranolol—migraine	9.99e-05	0.00206	CcSEcCtD
Levobunolol—Paraesthesia—Valproic Acid—migraine	9.85e-05	0.00203	CcSEcCtD
Levobunolol—Palpitations—Gabapentin—migraine	9.84e-05	0.00203	CcSEcCtD
Levobunolol—Confusional state—Timolol—migraine	9.84e-05	0.00203	CcSEcCtD
Levobunolol—Loss of consciousness—Gabapentin—migraine	9.79e-05	0.00202	CcSEcCtD
Levobunolol—Dyspnoea—Valproic Acid—migraine	9.78e-05	0.00202	CcSEcCtD
Levobunolol—Headache—Verapamil—migraine	9.69e-05	0.002	CcSEcCtD
Levobunolol—Shock—Timolol—migraine	9.6e-05	0.00198	CcSEcCtD
Levobunolol—Alopecia—Topiramate—migraine	9.51e-05	0.00196	CcSEcCtD
Levobunolol—Chest pain—Gabapentin—migraine	9.48e-05	0.00196	CcSEcCtD
Levobunolol—Pain—Valproic Acid—migraine	9.38e-05	0.00194	CcSEcCtD
Levobunolol—Nausea—Verapamil—migraine	9.19e-05	0.0019	CcSEcCtD
Levobunolol—Confusional state—Gabapentin—migraine	9.16e-05	0.00189	CcSEcCtD
Levobunolol—Hypotension—Timolol—migraine	9.12e-05	0.00188	CcSEcCtD
Levobunolol—Feeling abnormal—Valproic Acid—migraine	9.04e-05	0.00187	CcSEcCtD
Levobunolol—Shock—Gabapentin—migraine	8.94e-05	0.00185	CcSEcCtD
Levobunolol—Paraesthesia—Timolol—migraine	8.76e-05	0.00181	CcSEcCtD
Levobunolol—Urticaria—Valproic Acid—migraine	8.71e-05	0.0018	CcSEcCtD
Levobunolol—Dyspnoea—Timolol—migraine	8.7e-05	0.0018	CcSEcCtD
Levobunolol—ADRB1—GPCR ligand binding—HTR1D—migraine	8.5e-05	0.00367	CbGpPWpGaD
Levobunolol—Hypotension—Gabapentin—migraine	8.49e-05	0.00175	CcSEcCtD
Levobunolol—Syncope—Topiramate—migraine	8.4e-05	0.00174	CcSEcCtD
Levobunolol—Pain—Timolol—migraine	8.35e-05	0.00172	CcSEcCtD
Levobunolol—ADRB2—GPCR ligand binding—HTR1D—migraine	8.32e-05	0.00359	CbGpPWpGaD
Levobunolol—Palpitations—Topiramate—migraine	8.28e-05	0.00171	CcSEcCtD
Levobunolol—Loss of consciousness—Topiramate—migraine	8.24e-05	0.0017	CcSEcCtD
Levobunolol—Paraesthesia—Gabapentin—migraine	8.16e-05	0.00169	CcSEcCtD
Levobunolol—Dyspnoea—Gabapentin—migraine	8.1e-05	0.00167	CcSEcCtD
Levobunolol—Hypersensitivity—Valproic Acid—migraine	8.08e-05	0.00167	CcSEcCtD
Levobunolol—Feeling abnormal—Timolol—migraine	8.04e-05	0.00166	CcSEcCtD
Levobunolol—Chest pain—Topiramate—migraine	7.98e-05	0.00165	CcSEcCtD
Levobunolol—ADRB1—GPCR ligand binding—HTR2B—migraine	7.91e-05	0.00341	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	7.9e-05	0.0034	CbGpPWpGaD
Levobunolol—Asthenia—Valproic Acid—migraine	7.87e-05	0.00162	CcSEcCtD
Levobunolol—Pain—Gabapentin—migraine	7.77e-05	0.00161	CcSEcCtD
Levobunolol—Pruritus—Valproic Acid—migraine	7.76e-05	0.0016	CcSEcCtD
Levobunolol—Urticaria—Timolol—migraine	7.75e-05	0.0016	CcSEcCtD
Levobunolol—ADRB2—GPCR ligand binding—HTR2B—migraine	7.73e-05	0.00333	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	7.72e-05	0.00333	CbGpPWpGaD
Levobunolol—Confusional state—Topiramate—migraine	7.71e-05	0.00159	CcSEcCtD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	7.6e-05	0.00328	CbGpPWpGaD
Levobunolol—Shock—Topiramate—migraine	7.52e-05	0.00155	CcSEcCtD
Levobunolol—Diarrhoea—Valproic Acid—migraine	7.5e-05	0.00155	CcSEcCtD
Levobunolol—Feeling abnormal—Gabapentin—migraine	7.49e-05	0.00155	CcSEcCtD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	7.44e-05	0.00321	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	7.34e-05	0.00317	CbGpPWpGaD
Levobunolol—Dizziness—Valproic Acid—migraine	7.25e-05	0.0015	CcSEcCtD
Levobunolol—Urticaria—Gabapentin—migraine	7.22e-05	0.00149	CcSEcCtD
Levobunolol—Hypersensitivity—Timolol—migraine	7.19e-05	0.00149	CcSEcCtD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	7.18e-05	0.0031	CbGpPWpGaD
Levobunolol—Hypotension—Topiramate—migraine	7.15e-05	0.00148	CcSEcCtD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.14e-05	0.00308	CbGpPWpGaD
Levobunolol—Asthenia—Timolol—migraine	7e-05	0.00145	CcSEcCtD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	6.99e-05	0.00301	CbGpPWpGaD
Levobunolol—Pruritus—Timolol—migraine	6.91e-05	0.00143	CcSEcCtD
Levobunolol—Headache—Valproic Acid—migraine	6.87e-05	0.00142	CcSEcCtD
Levobunolol—Paraesthesia—Topiramate—migraine	6.87e-05	0.00142	CcSEcCtD
Levobunolol—Dyspnoea—Topiramate—migraine	6.82e-05	0.00141	CcSEcCtD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	6.77e-05	0.00292	CbGpPWpGaD
Levobunolol—Hypersensitivity—Gabapentin—migraine	6.7e-05	0.00138	CcSEcCtD
Levobunolol—Diarrhoea—Timolol—migraine	6.68e-05	0.00138	CcSEcCtD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	6.62e-05	0.00285	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—RAMP1—migraine	6.61e-05	0.00285	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CALCRL—migraine	6.61e-05	0.00285	CbGpPWpGaD
Levobunolol—Pain—Topiramate—migraine	6.54e-05	0.00135	CcSEcCtD
Levobunolol—Asthenia—Gabapentin—migraine	6.52e-05	0.00135	CcSEcCtD
Levobunolol—Nausea—Valproic Acid—migraine	6.51e-05	0.00135	CcSEcCtD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	6.51e-05	0.00281	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CALCRL—migraine	6.47e-05	0.00279	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—RAMP1—migraine	6.47e-05	0.00279	CbGpPWpGaD
Levobunolol—Dizziness—Timolol—migraine	6.45e-05	0.00133	CcSEcCtD
Levobunolol—Pruritus—Gabapentin—migraine	6.43e-05	0.00133	CcSEcCtD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	6.43e-05	0.00277	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.41e-05	0.00277	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.41e-05	0.00277	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	6.37e-05	0.00275	CbGpPWpGaD
Levobunolol—Feeling abnormal—Topiramate—migraine	6.3e-05	0.0013	CcSEcCtD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	6.29e-05	0.00271	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.29e-05	0.00271	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.27e-05	0.00271	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.27e-05	0.00271	CbGpPWpGaD
Levobunolol—Diarrhoea—Gabapentin—migraine	6.22e-05	0.00128	CcSEcCtD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.15e-05	0.00265	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.12e-05	0.00264	CbGpPWpGaD
Levobunolol—Headache—Timolol—migraine	6.11e-05	0.00126	CcSEcCtD
Levobunolol—Urticaria—Topiramate—migraine	6.07e-05	0.00125	CcSEcCtD
Levobunolol—Dizziness—Gabapentin—migraine	6.01e-05	0.00124	CcSEcCtD
Levobunolol—ADRB1—Signaling by GPCR—CALCRL—migraine	6.01e-05	0.00259	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—RAMP1—migraine	6.01e-05	0.00259	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.99e-05	0.00258	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CALCRL—migraine	5.88e-05	0.00253	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—RAMP1—migraine	5.88e-05	0.00253	CbGpPWpGaD
Levobunolol—Nausea—Timolol—migraine	5.8e-05	0.0012	CcSEcCtD
Levobunolol—Headache—Gabapentin—migraine	5.69e-05	0.00118	CcSEcCtD
Levobunolol—Hypersensitivity—Topiramate—migraine	5.63e-05	0.00116	CcSEcCtD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.51e-05	0.00238	CbGpPWpGaD
Levobunolol—Asthenia—Topiramate—migraine	5.49e-05	0.00113	CcSEcCtD
Levobunolol—Pruritus—Topiramate—migraine	5.41e-05	0.00112	CcSEcCtD
Levobunolol—Nausea—Gabapentin—migraine	5.4e-05	0.00112	CcSEcCtD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.39e-05	0.00232	CbGpPWpGaD
Levobunolol—Diarrhoea—Topiramate—migraine	5.23e-05	0.00108	CcSEcCtD
Levobunolol—ADRB1—GPCR ligand binding—HTR1B—migraine	5.15e-05	0.00222	CbGpPWpGaD
Levobunolol—Dizziness—Topiramate—migraine	5.06e-05	0.00104	CcSEcCtD
Levobunolol—ADRB2—GPCR ligand binding—HTR1B—migraine	5.04e-05	0.00217	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR1A—migraine	4.96e-05	0.00214	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—NPS—migraine	4.88e-05	0.00211	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—TAC1—migraine	4.88e-05	0.00211	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR1A—migraine	4.85e-05	0.00209	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR1D—migraine	4.81e-05	0.00207	CbGpPWpGaD
Levobunolol—Headache—Topiramate—migraine	4.79e-05	0.00099	CcSEcCtD
Levobunolol—ADRB1—GPCR ligand binding—HTR2C—migraine	4.79e-05	0.00207	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—NPS—migraine	4.78e-05	0.00206	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—TAC1—migraine	4.78e-05	0.00206	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR1D—migraine	4.7e-05	0.00203	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR2C—migraine	4.69e-05	0.00202	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—EDNRA—migraine	4.66e-05	0.00201	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—EDNRA—migraine	4.56e-05	0.00197	CbGpPWpGaD
Levobunolol—Nausea—Topiramate—migraine	4.54e-05	0.000938	CcSEcCtD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.5e-05	0.00194	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CALCA—migraine	4.48e-05	0.00193	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2B—migraine	4.47e-05	0.00193	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.41e-05	0.0019	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CALCA—migraine	4.39e-05	0.00189	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2B—migraine	4.37e-05	0.00188	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR1D—migraine	4.36e-05	0.00188	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR1D—migraine	4.27e-05	0.00184	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR7—migraine	4.2e-05	0.00181	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR7—migraine	4.1e-05	0.00177	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2B—migraine	4.06e-05	0.00175	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2B—migraine	3.97e-05	0.00171	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.86e-05	0.00166	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.77e-05	0.00163	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RAMP1—migraine	3.55e-05	0.00153	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CALCRL—migraine	3.55e-05	0.00153	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CALCRL—migraine	3.47e-05	0.0015	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RAMP1—migraine	3.47e-05	0.0015	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR2A—migraine	2.94e-05	0.00127	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR1B—migraine	2.91e-05	0.00126	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR2A—migraine	2.87e-05	0.00124	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR1B—migraine	2.85e-05	0.00123	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR1A—migraine	2.8e-05	0.00121	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—TAC1—migraine	2.76e-05	0.00119	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—NPS—migraine	2.76e-05	0.00119	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR1A—migraine	2.74e-05	0.00118	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2C—migraine	2.71e-05	0.00117	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—TAC1—migraine	2.7e-05	0.00116	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—NPS—migraine	2.7e-05	0.00116	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2C—migraine	2.65e-05	0.00114	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR1B—migraine	2.64e-05	0.00114	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—EDNRA—migraine	2.63e-05	0.00114	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR1B—migraine	2.59e-05	0.00112	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR1D—migraine	2.58e-05	0.00111	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—EDNRA—migraine	2.58e-05	0.00111	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR1A—migraine	2.55e-05	0.0011	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CALCA—migraine	2.53e-05	0.00109	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR1D—migraine	2.52e-05	0.00109	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—NPS—migraine	2.51e-05	0.00108	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—TAC1—migraine	2.51e-05	0.00108	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR1A—migraine	2.49e-05	0.00107	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CALCA—migraine	2.48e-05	0.00107	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2C—migraine	2.46e-05	0.00106	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—NPS—migraine	2.45e-05	0.00106	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—TAC1—migraine	2.45e-05	0.00106	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2C—migraine	2.4e-05	0.00104	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2B—migraine	2.4e-05	0.00103	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EDNRA—migraine	2.39e-05	0.00103	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR7—migraine	2.37e-05	0.00102	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2B—migraine	2.34e-05	0.00101	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EDNRA—migraine	2.34e-05	0.00101	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR7—migraine	2.32e-05	0.001	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CALCA—migraine	2.3e-05	0.000992	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CALCA—migraine	2.25e-05	0.000971	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR7—migraine	2.15e-05	0.000928	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LRP1—migraine	2.11e-05	0.00091	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR7—migraine	2.11e-05	0.000908	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LRP1—migraine	2.06e-05	0.00089	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2A—migraine	1.66e-05	0.000716	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2A—migraine	1.62e-05	0.0007	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOTCH4—migraine	1.62e-05	0.000698	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOTCH4—migraine	1.58e-05	0.000683	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR1B—migraine	1.56e-05	0.000673	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR1B—migraine	1.53e-05	0.000659	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2A—migraine	1.51e-05	0.00065	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR1A—migraine	1.5e-05	0.000648	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TAC1—migraine	1.48e-05	0.000638	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NPS—migraine	1.48e-05	0.000638	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PGR—migraine	1.48e-05	0.000638	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2A—migraine	1.47e-05	0.000636	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR1A—migraine	1.47e-05	0.000634	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2C—migraine	1.45e-05	0.000626	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TAC1—migraine	1.45e-05	0.000624	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NPS—migraine	1.45e-05	0.000624	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PGR—migraine	1.45e-05	0.000624	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2C—migraine	1.42e-05	0.000612	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EDNRA—migraine	1.41e-05	0.000609	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EDNRA—migraine	1.38e-05	0.000596	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOTCH3—migraine	1.38e-05	0.000593	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CALCA—migraine	1.36e-05	0.000586	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOTCH3—migraine	1.35e-05	0.000581	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CALCA—migraine	1.33e-05	0.000573	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR7—migraine	1.27e-05	0.000548	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR7—migraine	1.24e-05	0.000536	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFBR2—migraine	1.1e-05	0.000472	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFBR2—migraine	1.07e-05	0.000462	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2A—migraine	8.91e-06	0.000384	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2A—migraine	8.71e-06	0.000376	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ESR1—migraine	7.91e-06	0.000341	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ESR1—migraine	7.73e-06	0.000333	CbGpPWpGaD
